The New Times (Kigali)
30 September 2008
Over 21,000 Rwandans are expected to benefit from yet to be imported low-cost, generic Aids drug, Apo-TriAvir, The New Times has learnt.
[ See Article ]
Top | Site Français | Mobile | Who We Are | Advertising | Search My Account | Make us your home page | RSS | Contact | Privacy
